A cDNA clone encoding the a chain of the human T-cell antigen receptor was isolated by screening a library from the human T-cell line Jurkat with a mouse a-chain cDNA clone. This human a-chain clone, together with a human antigen receptor 3-chain cDNA clone, was used to determine the stage of T-cell development at which antigen receptor mRNAs first appear. Blot-hybridization analysis of mRNA isolated from a panel of human thymic tumor lines clearly demonstrated that 13-chain transcripts could be detected in all T-lineage cells. However, a-chain transcripts were only found in the most phenotypically mature lines, which express the antigen receptor-associated molecule T3. Furthermore, 13-chain transcripts were abundant in RNA prepared from purified T3-negative thymocytes, whereas a-chain transcripts were virtually absent. From these results we conclude that a-chain expression occurs later in thymic ontogeny than that of the 18 chain and propose that it controls surface expression of the antigen receptor-T3 complex.
Biochemical characterization of the T-cell antigen receptor has defined it as a disulfide-linked heterodimer (designated Ti) comprising an a and a p chain (1) (2) (3) . Although the af3 heterodimer is at least partially responsible for conferring antigenic specificity to a T cell, it is clear that several molecules are involved in T-cell activation in response to antigen. Most notable amongst these is the T3 glycoprotein, which apparently is associated physically with the Ti structure at the T-cell surface (4, 5); indeed, it has been suggested that coexpression of T3 and Ti at the cell surface is obligatory (5) . Knowledge of the stage of thymocyte ontogeny at which a and p chains (and T3) are expressed is important for any understanding of the acquisition of the T-cell repertoire and thymic education. It appears that p-chain transcripts are expressed at an early stage in thymic ontogeny because rearrangement of P-chain gene segments and high levels of p-chain mRNA have been detected in T-lineage tumors derived from immature [as defined on the basis of surface phenotype (6, 7)] thymocytes (8, 9) . Recently, cDNA clones encoding mouse (10, 11) and human (12) a chains have been described. In this paper we use a human a-chain cDNA clone to investigate a-chain mRNA expression during thymic ontogeny. We show that expression of p-chain mRNA precedes that of a-chain mRNA, which appears to be restricted to more mature thymocytes and T cells.
MATERIALS AND METHODS
Isolation and Sequencing of an a-Chain Clone. An amplified cDNA library (13) constructed in the vector Xgt 10, of 500,000 recombinant phage, was screened by standard procedures (14) with a constant region fragment from pHDS58 (10) . Five positive hybridizing clones were identified. The clone with the largest insert was subcloned into the EcoRI site of pBR322. This plasmid pJ6a2, was mapped and sequenced by the method of Maxam and Gilbert (15) .
Blot-Hybridization Analysis. Inserts from a-and P-chain plasmids were oligo-labeled (16) to specific activities of 2-6
x 108 cpm/,4g and hybridized to blots containing poly(A)+ RNA or total RNA denatured with formaldehyde prior to electrophoresing on 1.1% agarose gels (14) . After hybridization for 24 hr, blots were washed in 0.015 M NaCl/0.0015 M sodium citrate, pH 7, at 50'C (twice for 15 min each), and three different exposures were taken to ensure linearity of response during scanning densitometry. Surface Phenotype Analysis. The level of T3 expression in each batch of cells used to make RNA was determined by flow cytometric analysis using the antibody UCHT1 (kindly provided by P. Beverley).
RESULTS
The a-chain cDNA clone used in this study was isolated by screening a phage XgtlO library constructed by using RNA from the human leukemic T-cell line Jurkat (13) with a labeled insert from a mouse a-chain cDNA clone (10) . The insert from one positive clone (about 900 base pairs) was subcloned into pBR322 to yield the human a-chain clone pJ6a2. The sequence of this insert is shown in Fig. 1 Lower, and the sequencing strategy used is indicated in Fig. 1 Upper.
Comparison of this sequence with that of an homologous clone isolated by Sim et al. (12) from a HPB-MLT cDNA library reveals that the Jurkat cDNA clone commences at a position corresponding to amino acid 147 of the HPB-MLT clone and, thus, comprises about three-quarters of the constant region coding sequence plus almost the entire 3' untranslated region of the a-chain mRNA. The sequences of the two human a-chain clones are identical over the entire coding region but differ in several positions in the 3' untranslated region.
The Jurkat a-chain clone together with a 8-chain cDNA clone isolated from the same cDNA library (13) were used to determine the pattern of expression of the corresponding mRNAs by blot-hybridization analysis of mRNA isolated from various T-lineage cells. T3 expression was assessed on each batch of cells by using flow cytometry. When Jurkat mRNA was hybridized to the insert from pJ6a2, a transcript of about 1.4 kilobases (kb) was detected ( Fig. 2 Upper, Jurkat lanes). This transcript, which has been described previously by Sim et al. (12) , is specific to T-cell mRNA since it was not found in mRNA from two human lymphoblastoid B-cell lines (9) . In contrast, a-chain expression appears to occur later in thymocyte ontogeny and, therefore, could control surface expression of the antigen receptor and T3. Ifthis conclusion is correct, then a-chain expression would be expected to be low or undetectable in the immature thymocyte population that lacks T3. In order to assess this, total RNA was prepared from a purified T3-negative thymocyte population predominantly composed of immature thymocytes (6, 7). Sequences corresponding to the p-chain gene were abundant in T3-negative thymocytes (Fig. 3, lane  F) ; a-chain transcripts were, however, barely detectable (Fig. 3, lane E) . Both a-and p-chain sequences were easily visible in RNA isolated from total thymocytes (Fig. 3, lanes  C and D) .
When corrections were made for the different sizes and specific activities of the a-and P-chain probes, densitometric scans of several exposures of the blot hybridization shown in Fig. 2 revealed that the p8-chain 1.3-kb transcript was expressed in Jurkat at about twice the level of the 1.4-kb a-chain transcript and that ,-chain transcripts were also more abundant than a-chain transcripts in total thymocytes (Fig. 3) , whereas in peripheral blood T cells and the helper T-cell clone, the a-chain transcript was about 2-fold higher than the P8-chain transcript. Immunology: Collins et al.
Proc. Natl. Acad. Sci. USA 82 (1985) ation and may control the expression of Ti (and T3) at the thymocyte cell surface. However, one obvious caveat is that the stage at which mRNA for the three T3 polypeptides is first expressed in the cytoplasm is unknown. In contrast, P-chain expression most probably occurs at an early stage of differentiation, since p-chain transcripts were detected in every T-lineage tumor examined. These conclusions depend upon the assumption that the surface phenotype of a T-lineage tumor allows an accurate identification of the maturation stage from which that tumor was derived. The exact lineage interrelations of the various surface phenotypes are unclear; however, several lines of evidence indicate that at least early lineage (stage I) thymic tumors are accurate models for the immature thymocyte precursors of peripheral T cells (6, 7) . Moreover, blothybridization analysis of mRNA from T3-negative human thymocytes detected high levels of 8-chain transcripts but virtually no a-chain transcripts, a result that is consistent with the studies using T-lineage tumors and that strongly supports the idea of a-chain control of T3 expression.
The level of expression of a-chain mRNA sequences in the Sezary cell leukemia HUT 78 was less than 1% that of 8-chain transcripts. HUT 78 cells express T3 antigen and, consequently, would be expected to express Ti. In this context, the thymic tumor line Jurkat, total human thymocytes, peripheral blood T cells, and a human functional helper cell clone, which were positive for T3, expressed easily detectable amounts of a-chain transcripts. Two dimensional NaDodSO4 gel electrophoresis of surface-labeled HUT 78 cells has failed to detect a heterodimer-like Ti protein (19) . From the evidence presented here it is possible that the a chain does not constitute part of any Ti structure on HUT 78 cells. Therefore, T3 may be expressed on the surface of these cells in the absence of the ap8 heterodimer but may be associated with an additional Ti-like structure in which the 8 chain exists as a dimer or complexed with a third a-chain-like polypeptide. The unusual nature of the putative Ti structure on this tumor line may not be of physiological significance; alternatively, it may represent a normal stage in ontogeny.
Studies in the mouse and human systems have revealed that the functional variable-diversity-joining-constant region (V-D-J-C) p-chain transcripts are 1.3 kb in length, whereas the 1.0-kb mRNA corresponds to transcripts from incompletely rearranged loci lacking variable regions (13, 20, 21) . Similar aberrant rearrangements may also be a characteristic of a-chain genes, since a lower transcript has been detected in mouse T cells (10, 11) . It is clear, however, from the blot-hybridization analysis presented here that the level of expression of aberrant transcripts is considerably lower for a chains than for , chains. Thus, the only a-chain transcript detected in this study was the 1.4-kb productive transcript described previously by Sim et al. (12) . Southern hybridization analysis with a variety of restriction enzymes has failed to provide evidence for more than one human a-chain constant region (unpublished observation). The high level of aberrant p-chain, as opposed to a-chain, transcripts might reflect, therefore, the presence of two p-chain constant region genes per haploid genome or be a consequence of an intrinsically greater accuracy of the a-chain rearrangement machinery. However, as a-chain gene rearrangement probably follows that of,3 chain, it seems that the shut down of gene rearrangement machinery following productive a-chain mRNA appearance is likely to account for this difference.
Incomplete T-cell receptor gene rearrangements may occur in B cells because B-cell sequences that cross-hybridized with the a-chain probe were consistently observed in our blot-hybridization analyses (Fig. 2) . They also were detected at longer exposures using the p-chain probe (data not shown).
These transcripts were about 200-300 base pairs smaller than the productive a-and p-chain transcripts expressed in T cells and appeared to be specific, since they were not observed either in RNA from other tissues (erythroid, macrophage, or epithelial) or (in the case of the a chain) in T-cell lines not expressing 1.4-kb transcripts but were found in six lymphoblastoid B-cell lines tested. The levels of these B-cell transcripts varied considerably in different lymphoblastoid B-cell lines (see for example Fig. 2 Upper, BR18 and Maja lanes).
Their origin is unclear; however, they may be a consequence of the similar mechanisms that are thought to mediate rearrangement of T-cell receptor and B-cell immunoglobulin genes, as evidenced by the similar recognition sequences associated with the corresponding gene segments (22, 23) .
In conclusion, we have shown that mRNA encoding the a chain appears later in T-cell ontogeny than mRNA encoding the 8 chain. This result is in agreement with studies using fractionated mouse fetal and adult thymocyte populations and peripheral T cells (24) . The human T-cell surface antigen T3 is closely associated with the antigen receptor on the cell surface (4, 5) . We find that a-chain mRNA expression in thymus leukemia cell lines and in fractionated human thymocytes is correlated with the presence of T3. Therefore, a-chain expression may control the expression of the T3-Ti complex at the thymocyte cell surface. This hypothesis can be tested directly by transfection of a rearranged a-chain gene into an immature (stage I) thymic tumor line in order to induce the surface appearance of the T3-Ti structure.
